Impact of performance status on non-small-cell lung cancer...

  • Main
  • 2020 / 06
  • Impact of performance status on non-small-cell lung cancer...

Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab

Friedlaender, Alex, Metro, Giulio, Signorelli, Diego, Gili, Alessio, Economopoulou, Panagiota, Roila, Fausto, Banna, Giuseppe, De Toma, Alessandro, Camerini, Andrea, Christopoulou, Athina, Lo Russo, G
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Acta Oncologica
DOI:
10.1080/0284186X.2020.1781249
Date:
June, 2020
File:
PDF, 1.03 MB
2020
Conversion to is in progress
Conversion to is failed